InVitroLogics ApS: Financial statements 2022
CVR: 34044562
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
InVitroLogics ApS (CVR 34044562) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -64,465 and a net result of DKK -76,236 compared with DKK 36,994 the year before. Equity in the 2022 report amounted to DKK -395,303.
- Gross Profit
- DKK -64,465
- Profit/Loss
- DKK -76,236
- Equity
- DKK -395,303
- Total Assets
- DKK 14,862
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -64 t. | -76 t. | -395 t. | 0 |
| 2021 | 48 t. | 48 t. | 37 t. | -319 t. | - |
| 2020 | - | -41 t. | -41 t. | -356 t. | - |
| 2019 | - | -5 t. | -5 t. | -315 t. | - |
| 2018 | - | -5 t. | -16 t. | -309 t. | - |
Official annual report
Keep an eye on InVitroLogics ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
InVitroLogics ApS has published its annual report for 2021. Revenue came to DKK 47,735, and the net result was DKK 36,994.
About InVitroLogics ApS
InVitroLogics ApS is a Danish company of the type Anpartsselskab based in Slagelse, founded in 2011. The company is registered under the industry Detailhandel med andre medicinske og ortopædiske artikler. The management consists of Claus Pedersen Blicher. The company is owned by ADZUKI HOLDING ApS. According to the 2022 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -2,448 and a net result of DKK -2,448 compared with DKK -1,327 the year before. Equity in the 2025 report amounted to DKK -333,763.